PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for severe neuromuscular diseases, with key candidates targeting Duchenne muscular dystrophy (DMD) and myotonic dystrophy.
At the time of the alert, PepGen Inc. had 32.69 million shares outstanding and a float of 12.38 million shares. The company’s market capitalization was approximately $70 million, with an average daily volume of 250,000 shares. However, on the day of the alert, trading volume surged to 109,229,500 shares, marking an extraordinary 109,000% increase. This sharp rise in volume provided members with a prime opportunity to capitalize on a day trading strategy using ChatterFlow AI alerts, which tracks real-time social chatter momentum.
PepGen Inc. Stock Alert Stats | |
---|---|
Shares Outstanding | 32.69 Million |
Float | 12.38 Million |
Market Capitalization | $70 Million |
Average Daily Volume | 250,000 Shares |
Volume for the Day | 109,229,500 Shares |
Percentage Increase in Volume | 109,000% Increase |
Short Position | 852,550 Shares |
Short Percentage of Float | 5% |
Niche Industry | Neurological Biotechnology |
Movement for First Alert to Peak of Day | 109% Surge |
The surge in this biotech company’s stock was fueled by positive initial results from the ongoing FREEDOM-DM1 trial, igniting investor enthusiasm and drawing significant media coverage. ChatterFlow users, leveraging AI-driven alerts, acted quickly—buying in at a low price before the stock soared 109%—to capitalize on the gains.
